Viewing Study NCT06347133


Ignite Creation Date: 2025-12-25 @ 2:45 AM
Ignite Modification Date: 2026-03-03 @ 6:05 PM
Study NCT ID: NCT06347133
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-08
First Post: 2024-03-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 3 Study of Plozasiran in Adults With Hypertriglyceridemia
Sponsor: Arrowhead Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hypertriglyceridemia View
Keywords: